Castellanos-Morfín J, Hernández-Pérez P, Arellano-Cortés B, Newton-Sánchez OA, Espinoza-Gómez F

Language: Spanish
References: 22
Page: 202-206
PDF size: 47.36 Kb.

ABSTRACT

Introduction. There is little information about the effects of dengue infection upon the fetus, although the risk for this event increases during epidemic outbreaks. The vertical transmission of dengue is a rare event, a case is described below.
Case report. The patient was a male, born after 40 weeks of gestation and on the 5th day of a maternal febrile illness. His Apgar score was 8/9, with weight, size and cephalic perimeter in the range of the 50 percentile. On the first 24 hours after the delivery the patient developed fever and antibiotics was given for neonatal sepsis. On the postpartum day 4 he showed irritability, intense crying and hypereflexia, meanwhile the laboratory revealed thrombocytopenia and leucopoenia. Neuroinfection was presumed and treatment with phototherapy and cefotaxime was begun (the lumbar puncture was avoided because thrombocytopenia and prolonged TPT). The blood culture was negative. IgM antibodies for dengue virus were positive in both, mother and neonate. On postpartum day 12, both, mother and child were discharged from the hospital, asymptomatic and with normal laboratory values.
Conclusions. Usually, pregnant women with classic dengue have normal parturition and puerperium, as in this case. However, in the hemorrhagic dengue form there is an increased risk of delayed intrauterine growth, abortion, prematurity, premature rupture of membranes, preeclampsia and maternal or fetal death. The neonatal transmission of dengue is very rare, even in endemic countries with large epidemics; however it is an important condition that needs to be considered in the differential diagnosis of septic newborns in endemic areas.

REFERENCES

1. Méndez A, González G. Dengue hemorrágico en niños: diez años de experiencia clínica. Biomed. 2003; 23: 180-93.

2. Wills BA, Oragui EE, Stephens AC, Daramola OA, Dung NM, Loan HT, et al. Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis. 2002; 35: 277-85.

3. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis. 2000; 181: 2-9.

4. Espinoza-Gómez F, Hernández-Suárez CM, Rendón-Ramírez R, Carrillo-Álvarez ML, Flores-González JC. Transmisión interepidémica del dengue en la ciudad de Colima, México. Salud Publica Mex. 2003; 45: 365-70.

5. Escobar-Mesa J, Gómez-Dantés H. Determinantes de la transmisión de dengue en Veracruz: un abordaje ecológico para su control. Salud Publica Mex. 2003; 45: 43-53.

6. Ramos C, García H, Villaseca JM. Fiebre hemorrágica y síndrome de choque por dengue. Salud Publica Mex. 1993; 35: 39-55.

7. González G, Guerra A, Malavé L, Pérez P. Dengue neonatal. A propósito de un caso. Arch Venez Puer Pediatr. 2001; 64: 219-22.

8. Rivas-Llamas R, Chaín-Castro RA, Murillo-Llanes J, Ramírez-Zepeda MG, Gadea-Álvarez T, López-López E. Manifestaciones hemorrágicas en el dengue. Rev Biomed. 2005; 16: 87-94.

9. Carles G, Peiffer H, Talarmin A. Effects of dengue fever during pregnancy in French Guiana. Clin Infect Dis. 1999; 28: 637-40.

10. Jasso-Gutiérrez L. Infecciones congénitas poco habituales de transmisión vertical. Bol Med Hosp Infant Mex. 2006; 63: 55-63.

11. Secretaría de Salud. Sistema Único de Información para la Vigilancia Epidemiológica 2003. Información preliminar. Casos por entidad federativa de enfermedades transmisibles por vector. Vigilancia epidemiológica. Semana 52, cuadro 7.1. México, D. F.: Secretaría de Salud; 2003.

12. Secretaría de Salud. Coordinación de Vigilancia Epidemiológica. Programa Nacional de Vigilancia, prevención y control del dengue. Dengue y dengue hemorrágico: Guía práctica para su diagnóstico, manejo y tratamiento. México: Secretaría de Salud; 2002.

13. Restrepo-Jaramillo BN, Isaza-Guzmán DM, Salazar-González CL, Upegui-Londoño G, Duque CL, Ospina-Opsina M, et al. Efectos del virus del dengue durante el embarazo. Medellín, Colombia. Infection. 2002; 6: 197-203.

14. López-Barroso R, Deulofeu-Betancourt I, Domínguez-Eljaiek CF. Repercusión del dengue sobre el embarazo. MEDISAN. 2002; 6: 18-24.

15. Carles G, Talarmin A, Peneau C, Bertsch M. Dengue fever and pregnancy. A study of 38 cases in French Guiana. J Gynecol Obstet Biol Reprod. 2000; 29: 758-62.

16. Kerdpanich A, Watanaveeradej V, Samakoses R, Chumanvanakij S, Chulyamitporn T, Sumeksri P, et al. Perinatal dengue infection. Southeast Asian J Trop Med Public Health. 2001; 32: 488-93.

17. Boussemart T, Babe P, Sibille G, Neyret C, Berchel C. Prenatal transmission of dengue: two new cases. J Perinatol. 2001; 21: 255-7.

18. Chye JK, Lim ChT, Ng KB, Lim JMH, George R, Lam SK. Vertical transmission of dengue. Clin Infect Dis. 1997; 25: 1374-7.

19. Thaithumyanon P, Thisyakorn U, Deerojnawong J, Innis BL. Dengue infection complicated by severe hemorrhage and vertical transmission in a parturient woman. Clin Infect Dis. 1994; 18: 248-9.

20. Organización Panamericana de la Salud. Boletín Epidemiológico. Normas y Estándares en Epidemiología. Definiciones de casos: Dengue y Leptospirosis. OPS; Junio; 2000. Vol. 21, No. 2.

21. Bethell DB, Gamble J, Loc PP, Dung NM, Chau TTH, Loan HT, et al. Noninvasive measurement of microvascular leakage in patients with dengue hemorrhagic fever. Clin Infect Dis. 2001; 32: 243-53.

22. Palacios-Serrano H, Vargas-Caballero ME, Aguirre-Portuondo TM. Dengue hemorrágico en dengue primario. Rev Cubana Med Trop. 2001; 53: 59-62.